Enteric-Coated Aspirin Versus Other Antiplatelet Drugs in Acute Non-Cardioembolic Ischemic Stroke: Post-marketing Study in Japan.

CONCLUSION: It seems that these results showed the safety and efficacy of the enteric-coated aspirin in acute stroke care in Japanese patients. Incidence of hemorrhagic events was comparable between the enteric-coated aspirin group and the other antiplatelet drugs group. PMID: 24385407 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24385407?dopt=Abstract

Source: Advances in Therapy - January 3, 2014 Category: Drugs & Pharmacology Authors: Takahashi S, Mizuno O, Sakaguchi T, Yamada T, Inuyama L Tags: Adv Ther Source Type: research